ClinicalTrials.gg
Active, not recruitingNCT04229017FUSEUpdated Oct 30, 2025

Study of Posterior Cervical Stabilization System (PCSS) as Part of Circumferential Fusion to Treat Multilevel DDD

An interventional study of Anterior Cervical Discectomy and Fusion and Posterior Cervical Stabilization System (PCSS) in Degenerative Disc Disease, sponsored by Providence Medical Technology, Inc.. Active, not recruiting at 17 sites in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-10-30.

Sponsored by Providence Medical Technology, Inc. · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
236
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 232 studies in Intervertebral Disc Degeneration with a site in United States — 41 open to participants now, 58 under way, 5 of them phase 3. Intervertebral Disc Degeneration · United States.

Planned enrollment
21st of 141
236 · median 57
Started
2020
with 16 others
No phase
90 of 232
15 open now
Primary completion
2024-07
later than 1 of 57 live
Registered
152nd of 232
by date

Among the 232 studies in Intervertebral Disc Degeneration with a site in United States, this one is the 21st largest by planned enrollment of the 141 interventional ones that give a count, is one of 17 that started in 2020, is one of 90 with no phase, reaches primary completion later than 1 of the 57 other live ones, and was the 152nd registered.

Intervertebral Disc Degeneration

462 studies on the registry are indexed under Intervertebral Disc Degeneration; 100 are open to participants now.

Browse Intervertebral Disc Degeneration studies →

Open to participants now

41 of the 232 studies in Intervertebral Disc Degeneration with a site in United States are open now. Recruiting first, the newest first:

36 more — sign in →

All 41 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 60 Intervertebral Disc Degeneration studies recruiting now, 29 (48%) set no upper age limit and 16 (27%) stop at 75 or younger; 7 take children under 18; 5 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 232 studies in Intervertebral Disc Degeneration with a site in United States, or all of them as a file.
02

Study summary

This study will evaluate the safety and effectiveness of a device called "Posterior Cervical Stabilization System or PCSS" when used along with posterior cervical fusion (PCF) in combination with anterior cervical discectomy and fusion (ACDF) in the treatment of multi-level cervical degenerative disease.

Read the detailed description

Degenerative disc disease (DDD) is a condition in which people experience pain because of compression on the spinal cord or nerve roots caused by degenerating cervical discs. Discs sit between the bones of the spine to provide cushioning, shock absorption, mobility, and load-bearing. When the discs break down, the space between the bones gets smaller and squeezes on the spinal cord or nerve roots causing radiating pain down the neck, shoulders, or arms.

A surgical approach to address cervical (neck) DDD is to fuse the bones together to prevent further compression. This can be done with or without removing the disc material itself. The most common way to perform a cervical spinal (neck) fusion to address DDD is to come in from the front of the neck, decompress the spine to relieve pain, and fuse the bones together to prevent further pain in a procedure called Anterior Cervical Discectomy and Fusion (ACDF). Another option is to come in from the back of the neck in a procedure called Posterior Cervical Fusion (PCF). Sometimes these procedures are combined to provide further decompression and stability in the bones of the neck to promote fusion leading to quicker pain relief and return to function.

03

Conditions studied

  • Degenerative Disc Disease

Keywords

  • cervical spine
  • myelopathy
  • radiculopathy
  • cervical spine fusion
  • circumferential cervical fusion
  • degenerative disease
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 18-80 years (Skeletally Mature)
  2. Indicated for ACDF treatment of degenerative disc disease (DDD) between and including C3-C7 at 3 contiguous levels
  3. NDI Score of ≥15/50
  4. Unresponsive to non-operative, conservative treatment (rest, heat, electrotherapy, physical therapy, chiropractic care and/or analgesics)
  5. Reported to be medically cleared for surgery
  6. Physically and mentally able and willing to comply with the Protocol, including the ability to read and complete required forms and willing and able to adhere to the scheduled follow-up visits and requirements of the Protocol.
  7. Written provided by subject

Exclusion criteria

Exclusion Criteria:

  1. (BMI) greater than 40 kg/m2
  2. Active systemic infection or infection at the operative site
  3. History of or anticipated treatment for active systemic infection, including or
  4. Previous trauma to the C3 to C7 levels resulting in significant bony or disco- ligamentous cervical spine injury that may prevent device placements
  5. A prior spine surgery or pseudoarthrosis at the operative levels
  6. Axial neck pain in the absence of other symptoms of radiculopathy or myeloradiculopathy justifying the need for surgical intervention
  7. Symptomatic DDD or significant cervical spondylosis at more than three levels
  8. Diagnosis of spondylolisthesis, grade >2
  9. Overt (Segmental) instability measured as a movement on dynamic flex/ext x-rays >3.5 mm
  10. Congenital bony and/or spinal cord abnormalities that affect spinal stability
  11. Diagnosis of Paget's disease, osteomalacia or any other metabolic bone disease other than osteoporosis
  12. Osteoporosis, defined as either the SCORE or MORES ≥ 6 and a DEXA bone density measured T-score of ≤ -2.5
  13. Active or a history of any invasive malignancy (except non-melanoma skin cancer), unless treated with curative intent and without clinical signs or symptoms of the malignancy for at least five years
  14. Has an uncontrolled seizure disorder
  15. Use of epidural within 14 days prior to surgery
  16. A concomitant condition requiring daily, high-dose oral and/or inhaled steroids
  17. Known allergy to titanium (Ti).
  18. Fixed or permanent neurologic deficit related to the target treatment levels that cannot be improved with surgical decompression
  19. Has, in the Investigator's opinion, any disease or condition that would preclude accurate clinical evaluation (e.g. neuromuscular disorders).
  20. Is pregnant or nursing at time of screening, or with plans to become pregnant within the next three years.
  21. A current or recent history (≤ 1 year prior to screening) of substance abuse (alcoholism and/or narcotic addiction) that required treatment.
  22. Long term use (>6 months) of opioids (max. daily amount=120 mg morphine equivalents).
  23. A mental illness or belongs to a vulnerable population, as determined by the investigator (e.g., prisoner or developmentally disabled), that would compromise ability to provide or compliance with follow-up requirements.
  24. Any other condition or anatomy (e.g. fused facet) that makes posterior fusion treatment infeasible
  25. Use of any other drug or medical device within the last 30 days prior to surgery.
  26. A pending personal litigation relating to spinal injury (worker's compensation is not exclusionary).
  27. Anticipated or potential relocation greater than 50 miles that may interfere with completion of follow-up examinations.
Terms in these criteria, in plain language(7)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

Hepatitis C tests

Hepatitis C is a virus that infects the liver. An HCV antibody test can stay positive after an infection has cleared (and is occasionally positive without one); an HCV RNA test shows whether the virus is there now.

After treatment, hepatitis C counts as cured when HCV RNA is still undetectable 12 weeks or more after the treatment ended. Studies often accept people cured this way.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
236 participants (estimated)

Study arms

  • Active comparator
    Anterior Cervical Discectomy and Fusion (ACDF)

    ACDF is a a standard of care procedure that is performed using standard instruments and completed with an allograft interbody implant and anterior plate. The plate is intended to stabilize the treated levels until fusion occurs.

    Procedure: Anterior Cervical Discectomy and Fusion

  • Experimental
    Circumferential Cervical Fusion (CCF)

    Circumferential Cervical Fusion (CCF) is a combination of ACDF and Posterior Cervical Fusion (PCF) procedures. The PCF is completed with Posterior Cervical Stabilization System (PCSS).

    Device: Posterior Cervical Stabilization System (PCSS)

Interventions

  • ProcedureAnterior Cervical Discectomy and Fusion

    Anterior Cervical Decompression and Fusion (ACDF) is a standard of care procedure that is performed using standard instruments and completed with an allograft interbody implant and anterior plate.

    Also known as: ACDF

  • DevicePosterior Cervical Stabilization System (PCSS)

    Posterior Cervical Stabilization System (PCSS) is non-segmental instrumentation with integrated screw fixation intended to provide immobilization and stabilization of spinal segments. PCSS achieves bilateral facet fixation by spanning the interspace at each level with points of fixation at each end of the construct.

06

What researchers measure

Primary outcomes

  1. Superiority in Fusion Success in CCF (treatment) compared to ACDF (control)

    An individual subject is considered a fusion success if there is evidence of bridging trabecular bone across endplates and \< 2° total angular motion

    Time frame: 12 months

Secondary outcomes

  1. Non-inferiority Composite Safety Success in CCF (treatment) compared to ACDF (control)

    An individual subject is considered a success if all of the following safety criteria are met: 1. Fusion success - as defined by evidence of bridging trabecular bone across endplates and \< 2° total angular motion 2. Improvement in Neck Disability Index (NDI) 3. Improvement in Neurological function 4. Absence of secondary surgical interventions (SSI)

    Time frame: 24 months

07

Study locations

17 sites
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2020 to primary completion in Jul 2024, 52 months.

Of 45 industry-sponsored interventional studies with no phase under Intervertebral Disc Degeneration, half reached primary completion within 52 months of starting (the median), counting those still running; a quarter within 43 and three quarters within 82. This study's 52 months is close to that.

Counting every sponsor, half of 85 studies reached it within 50 months; a quarter within 27 and three quarters within 72.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 23, 2019
First posted
Jan 14, 2020
StartActual
Mar 18, 2020
Primary completionActual
Jul 22, 2024
CompletionEst.
Dec 2025
Last update
Oct 30, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04229017
Lead sponsor
Providence Medical Technology, Inc.
Responsible party
Sponsor
First posted
Jan 14, 2020
Start date
Mar 18, 2020
Primary completion
Jul 22, 2024
Completion
Dec 2025 (estimated)
Last update
Oct 30, 2025

Study contacts

Matt Jenkins
study director · Providence Medical Technology, Inc.

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion